Published in Medical Imaging Business Week, July 29th, 2004
One conclusion in particular from these presentations indicated that based upon AI-700's phase II results, stress myocardial perfusion echo with AI-700 performed well in a comparison with nuclear stress perfusion in patients being evaluated for coronary heart disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.